| 克服试验误差 |
| |
| 作者姓名： | Lawrence A Meinert Qing Zuraw |
| |
| 作者单位： | [1]Covance美国公司医疗和科学事物副总裁 [2]Covance中国公司晚期开发服务的副医疗主任 |
| |
| 摘 要： | 新型高选择性药品的出现推动更大更复杂试验的趋势。日益增长的治疗复杂性激发西欧和北美的研究者寻找方法来实现临床增长的要求。
|
| 关 键 词： | 试验误差 高选择性 复杂性 研究者 |
Removing error from trials |
| |
| Lawrence A Meinert Qing Zuraw.Removing error from trials[J].Automotive Manufacturer,2006(2):68-70,72,73. |
| |
| Authors: | Lawrence A Meinert Qing Zuraw |
| |
| Institution: | Vice-President of Medical and Scientific Affairs, Late Stage Developmen t Services, Covance US; Associate Medical Director of Late Stage Development Services, Covance China |
| |
| Abstract: | The emergence of a new class of highly selective drugs is driving a trend towards larger and more intricate trials. This growing therapeutic complexity is motivating investigators in Western Europe and North America to look further to fulfil the increasing demands of clinical research. |
| |
| Keywords: | |
| 本文献已被 维普 等数据库收录！ |
